Compare GEHC & FNV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GEHC | FNV |
|---|---|---|
| Founded | 1892 | 1986 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Computer Software: Prepackaged Software | Precious Metals |
| Sector | Technology | Basic Materials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 38.9B | 40.1B |
| IPO Year | N/A | 2007 |
| Metric | GEHC | FNV |
|---|---|---|
| Price | $79.23 | $255.07 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 12 | 8 |
| Target Price | $91.17 | ★ $235.88 |
| AVG Volume (30 Days) | ★ 3.8M | 1.1M |
| Earning Date | 02-04-2026 | 03-10-2026 |
| Dividend Yield | 0.18% | ★ 0.64% |
| EPS Growth | ★ 4.84 | N/A |
| EPS | 4.55 | ★ 4.77 |
| Revenue | ★ $20,625,000,000.00 | $1,531,400,000.00 |
| Revenue This Year | $5.90 | $58.95 |
| Revenue Next Year | $4.52 | $27.97 |
| P/E Ratio | ★ $17.38 | $52.06 |
| Revenue Growth | 4.84 | ★ 40.88 |
| 52 Week Low | $57.65 | $137.05 |
| 52 Week High | $94.80 | $273.56 |
| Indicator | GEHC | FNV |
|---|---|---|
| Relative Strength Index (RSI) | 44.14 | 59.98 |
| Support Level | $78.59 | $222.97 |
| Resistance Level | $85.54 | $243.99 |
| Average True Range (ATR) | 2.20 | 10.70 |
| MACD | -0.04 | -1.75 |
| Stochastic Oscillator | 22.17 | 63.32 |
GE HealthCare Technologies is a leading medical technology firm with leading market share in imaging and ultrasound equipment. The company reports four major segments: imaging (45% of revenue), advanced visualization solutions (26%), patient care solutions (16%), and pharmaceutical diagnostics (13%). The company's sales are geographically diverse, with the United States, EMEA, China, and the rest of the world accounting for 46%, 26%, 12%, and 17% respectively. We estimate approximately half of its revenue is recurring, which consists of servicing (about one third of revenue), pharmaceutical diagnostics (about 10%-15%), and digital solutions (just over 5%).
Franco-Nevada Corp is a precious-metals-focused royalty and investment company. The company owns a diversified portfolio of precious metals and royalty streams, which is actively managed to generate the bulk of its revenue from gold, silver, and platinum. The company does not operate mines, develop projects, or conduct exploration. The company's short-term financial performance is linked to the price of commodities and the amount of production from its portfolio of producing assets. Its long-term performance is affected by the availability of exploration and development capital. The company holds a portfolio of assets, diversified by commodity, revenue type, and stage of a project.